Items where authors include "Perren, TJ"

Article

Stevens, W, Farrow, IM, Georgiou, L et al. (9 more authors) (2021) Breast tumour volume and blood flow measured by MRI after one cycle of epirubicin and cyclophosphamide-based neoadjuvant chemotherapy as predictors of pathological response. The British Journal of Radiology. 20201396-. ISSN 0007-1285

Colomban, O, Tod, M, Peron, J et al. (6 more authors) (2020) Bevacizumab for Newly Diagnosed Ovarian Cancers: Best Candidates Among High-Risk Disease Patients (ICON-7). JNCI Cancer Spectrum, 4 (3). pkaa026. pkaa026-. ISSN 1475-4029

Hall, M, Bertelli, G, Li, L et al. (7 more authors) (2020) Role of front-line bevacizumab in advanced ovarian cancer: the OSCAR study. International Journal of Gynecological Cancer, 30 (2). pp. 213-220. ISSN 1048-891X

Georgiou, L, Wilson, DJ, Sharma, N et al. (2 more authors) (2019) A functional form for a representative individual arterial input function measured from a population using high temporal resolution DCE MRI. Magnetic Resonance in Medicine, 81 (3). pp. 1955-1963. ISSN 0740-3194

Laes, J-F, Aftimos, P, Barthelemy, P et al. (28 more authors) (2018) The clinical impact of using complex molecular profiling strategies in routine oncology practice. Oncotarget, 9 (29). pp. 20282-20293. ISSN 1949-2553

Perren, TJ orcid.org/0000-0001-8472-8856 (2016) Mucinous epithelial ovarian carcinoma. Annals of Oncology, 27 (S1). i53-i57. ISSN 0923-7534

Ledermann, JA, Embleton, AC, Raja, F et al. (16 more authors) (2016) Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial. The Lancet, 387 (10023). pp. 1066-1074. ISSN 0140-6736

Oza, AM, Cook, AD, Pfisterer, J et al. (21 more authors) (2015) Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial. Lancet Oncology, 16 (8). pp. 928-936. ISSN 1470-2045

Perren, TJ orcid.org/0000-0001-8472-8856, Swart, AM, Pfisterer, J et al. (23 more authors) (2011) A Phase 3 Trial of Bevacizumab in Ovarian Cancer. New England Journal of Medicine, 365. pp. 2484-2496. ISSN 0028-4793

Spencer, JA and Perren, TJ orcid.org/0000-0001-8472-8856 (2010) Recent EORTC and MRC UK studies: implications for imaging ovarian cancer. Cancer Imaging, 10 (1). pp. 135-136. ISSN 1740-5025

Thorpe, HC, Brown, SR, Sainsbury, JR et al. (5 more authors) (2007) Timing of breast cancer surgery in relation to menstrual cycle phase: No effect on three-year prognosis: The ITS Study. British Journal of Cancer, 98 (1). 39 - 44. ISSN 0007-0920

Hall, GD orcid.org/0000-0002-8864-5932, Brown, JM orcid.org/0000-0002-2719-7064, Coleman, RE et al. (8 more authors) (2004) Maintenance treatment with interferon for advanced ovarian cancer: results of the Northern and Yorkshire gynaecology group randomised phase III study. British Journal of Cancer, 91 (4). pp. 621-626. ISSN 0007-0920

Humphreys, AC, Dent, J, Rodwell, S et al. (5 more authors) (2004) Phase II study of docetaxel in combination with epirubicin and protracted venous infusion 5-fluorouracil (ETF) in patients with recurrent or metastatic breast cancer. A Yorkshire breast cancer research group study. British Journal of Cancer, 90 (11). pp. 2131-2134. ISSN 0007-0920

Dent, J, Hall, GD, Wilkinson, N et al. (5 more authors) (2003) Cytogenetic alterations in ovarian clear cell carcinoma detected by comparative genomic hybridisation. British Journal of Cancer, 88 (10). pp. 1578-1583. ISSN 0007-0920

Cameron, DA, Anderson, A, Toy, E et al. (9 more authors) (2002) Block sequential adriamycin CMF – optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer? British Journal of Cancer, 87 (12). pp. 1365-1369. ISSN 0007-0920

Adams, M, Calvert, AH, Carmichael, J et al. (20 more authors) (1998) Chemotherapy for ovarian cancer - a consensus statement on standard practice. British Journal of Cancer, 78 (11). pp. 1404-1406. ISSN 0007-0920

Joffe, JK, Perren, TJ orcid.org/0000-0001-8472-8856, Bradley, C et al. (5 more authors) (1997) A phase II study of recombinant interferon-β (r-hIFN-β 1a) in combination with 5-fluorouracil (5-FU) in the treatment of patients with advanced colorectal carcinoma. British Journal of Cancer, 75 (3). pp. 423-426. ISSN 0007-0920

Perren, TJ orcid.org/0000-0001-8472-8856 (1995) Paclitaxel (Taxol) in relapsed and refractory ovarian cancer: the UK and Eire experience. British Journal of Cancer, 72 (4). pp. 1016-1019. ISSN 0007-0920

Perren, TJ orcid.org/0000-0001-8472-8856, Wiltshaw, E, Harper, P et al. (6 more authors) (1993) A randomised study of carboplatin vs sequential ifosfamide/carboplatin for patients with FIGO stage III epithelial ovarian carcinoma. British Journal of Cancer, 68 (6). pp. 1190-1194. ISSN 0007-0920

Banks, RE, Gearing, AJ, Hemingway, IK et al. (3 more authors) (1993) Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. British Journal of Cancer, 68 (1). pp. 122-124. ISSN 0007-0920

Ward, U, Primrose, JN, Finan, PJ et al. (4 more authors) (1993) The use of tumour markers CEA, CA-195 and CA-242 in evaluating the response to chemotherapy in patients with advanced colorectal cancer. British Journal of Cancer, 67 (5). pp. 1132-1135. ISSN 0007-0920

Perren, TJ orcid.org/0000-0001-8472-8856 (1991) c-erbB-2 oncogene as a prognostic marker in breast cancer. British Journal of Cancer, 63 (3). pp. 328-332. ISSN 0007-0920

Perren, TJ, Selby, PJ, Milan, S et al. (2 more authors) (1990) Etoposide and adriamycin containing combination chemotherapy (HOPE-BLEO) for relapsed Hodgkin’s disease. British Journal of Cancer, 61 (6). pp. 919-923. ISSN 0007-0920

Lakhani, S, Selby, P, Bliss, JM et al. (3 more authors) (1990) Chemotherapy for malignant melanoma: Combinations and high doses produce more responses without survival benefit. British Journal of Cancer, 61 (2). pp. 330-334. ISSN 0007-0920

Zulian, GB, Selby, P, Milan, S et al. (5 more authors) (1989) High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin’s disease. British Journal of Cancer, 59 (4). pp. 631-635. ISSN 0007-0920

Selby, PJ, Powles, RL, Easton, D et al. (6 more authors) (1989) The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation. British Journal of Cancer, 59 (3). pp. 434-438. ISSN 0007-0920

Mbidde, EK, Selby, PJ, Perren, TJ orcid.org/0000-0001-8472-8856 et al. (6 more authors) (1988) High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma. British Journal of Cancer, 58 (6). pp. 779-782. ISSN 0007-0920